Winter Edition 2021

In his first Magazine letter since becoming BSF’s Executive Director, Anton Post – himself a former BSF grantee – shares how his appreciation for the contributions of US-Israel science collaborations has grown even further during these challenging times.

Shortly after becoming the 47th BSF grantee to receive a Nobel Price, Dr. Rice sat down with BSF for a far-reaching Zoom conversation, where he discussed his career, his current BSF project, the importance of US-Israel science partnerships – and some of the stranger aspects of becoming a Nobel laureate. (Hint: He now gets asked to autograph photos of his dogs.)

Throughout her career, Dr. Iris Eisenberg has made a name for herself as a trailblazing biologist. As a new member of BSF’s Board of Governors, Eisenberg hopes to help Israeli and American scientists to follow paths toward their own discoveries.

Already a pioneer in the discovery of the hepatitis C virus, Nobel Prize winner Dr. Charles Rice is teaming with Dr. Amir Shlomai to examine the connection between hepatitis B and liver cancer, with the hope that their work will eventually lead to new drugs that will significantly prolong patients’ lives.

Neufeld Award winners study key issues relating to weight loss, brain tumors Since its inception more than 20 years ago, BSF’s Neufeld Award has meant important early recognition for young Israeli and U.S. scientists in the health field. The award honors the memory of BSF advocate Prof. Henry…

Two teams of Israeli and American researchers – one pair with eyes on ancient civilization, and the other on taming a modern-day infectious bacterium – are the latest winners of BSF’s Bergmann Memorial Award. Read more about their projects and the discoveries they hope to make.

…that cancer patients might have heightened COVID 19 fighting ability?  It seems to defy logic, but Israeli cancer expert and recent BSF-grantee Prof. Yuval Shaked, just published a study in the peer-reviewed journal Cancers that points to the weakened immune system of oncology patients acting as a potential bulwark against…